Chart calendar Sucampo Pharmaceuticals, Inc.
Upcoming events on Sucampo Pharmaceuticals, Inc.
No events available
Past events on Sucampo Pharmaceuticals, Inc.
07/03/2018 | FY 2017 Earnings Release (Projected) |
04/12/2017 | Mizuho Americas Global Investor Conference |
28/11/2017 10:00 pm | Piper Jaffray Health Care Conference |
16/11/2017 07:30 pm | R&D Day |
01/11/2017 06:00 pm | Q3 2017 Earnings Call |
01/11/2017 | Q3 2017 Earnings Release Pre-market |
05/10/2017 01:45 am | Deutsche Bank U.S. Leveraged Finance Conference |
28/09/2017 01:00 am | LEERINK Partners Rare Disease & Immuno-Oncology Conference |
26/09/2017 09:00 pm | Cantor Fitzgerald Global Healthcare Conference |
06/09/2017 11:55 pm | Wells Fargo Securities Health Care Conference |
02/08/2017 06:00 pm | Interim 2017 Earnings Call |
02/08/2017 | Interim 2017 Earnings Release Pre-market |
09/06/2017 12:00 am | Jefferies Global Health Care Conference |
01/06/2017 | Annual General Meeting |
18/05/2017 08:30 pm | Bank of America Merrill Lynch Health Care Conference |
04/05/2017 10:00 pm | Deutsche Bank Health Care Conference |
03/05/2017 06:00 pm | Q1 2017 Earnings Call |
03/05/2017 | Q1 2017 Earnings Release Pre-market |
14/03/2017 | FY 2016 Earnings Release (Projected) |
17/02/2017 02:00 am | Leerink Global Healthcare Conference |
Past sector events for Sucampo Pharmaceuticals, Inc.
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |